CClinicalTrials.gg
CompletedNCT04366557Updated Apr 29, 2020

The Influence of the Body Posture Correcting Therapy on Pelvic Floor Muscles Function

An interventional study of Manual therapy, exercises and education program and Education program in Urinary Incontinence,Stress, sponsored by Katarzyna Jórasz. Completed at 1 site in Poland. Open to female participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-04-29.

Sponsored by Katarzyna Jórasz · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jan 2019, registered Apr 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
Female
01

Study summary

The purpose of this study is to assess the influence of the body posture correcting therapy on pelvic floor muscles function and urinary incontinence problem.

Read the detailed description

This randomized, controlled study was aimed to asses influence of a six week global posture correction therapy on pelvic floor muscles function and urinary incontinence problem. Participants were randomly divided into two groups. All subjects overcame assessment of pelvic floor muscles (sEMG, manometry and digital) and completed questionnaire about urinary incontinence problem and general health condition connected with lower tract symptoms. Both groups had a pelvic floor education (what is it, where are the pelvic floor muscle, how to correct contract them etc.) Additionally, the study group had a six week therapy focused on body posture correction. Therapy consisted of manual therapy (once per week) and correction exercises.

02

Conditions studied

  • Urinary Incontinence,Stress
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's enrollment of 60 is close to the median of 66 across 1,011 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

This is the only study on the registry with Katarzyna Jórasz as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • stress urinary incontinence (confirmed by a medical examination)
  • female
  • age between 25 and 45 years old

Exclusion criteria

Exclusion Criteria:

  • gynecological, spinal, and abdominal surgery (excluding cesarean delivery)
  • menopause
  • spinal and pelvis injuries
  • chronic diseases of the circulatory and respiratory system
  • neurlogical accidance
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Body posture correction

    Subjects from study group had an education about pelvic floor and additional a six week body posture therapy.

    Other: Manual therapy, exercises and education program

  • Other
    Without correction of body posture

    Subjects form control group had only an education about pelvic floor.

    Other: Education program

Interventions

  • OtherManual therapy, exercises and education program

    a six week body posture therapy consisted of manual therapy (once per week) and home exercises; education about pelvic floor

  • OtherEducation program

    education about pelvic floor

06

What researchers measure

Primary outcomes

  1. Change in Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-SF)

    evaluating the frequency, severity and impact on quality of life (QoL) of urinary incontinence; scoring scale 0-21 (higher scores mean a worse outcome)

    Time frame: 6 week (post-treatment)

  2. Change in Oswestry Disability Index (ODI)

    level of disability connected with chronic lumbar pain; scoring scale 0-50 (higher scores mean a worse outcome)

    Time frame: 6 week (post-treatment)

  3. Change in King's Health Questionnaire (KHQ)

    to assess the impact of lower urinary tract symptoms including urinary incontinence on health related quality of life; the questionnarie consists of three parts; scoring scale: I-II part 0-100; III part 0-30 (higher scores mean a worse outcome)

    Time frame: 6 week (post-treatment)

  4. Change in sEMG of the pelvic floor muscles

    using vaginal probe; average maximum voluntary isometric contraction and relaxation (after 5 attempts); unit of measure - mV (microvolts); higher scores mean a better outcome (contraction); higher scores mean the worse outcome (relaxation)

    Time frame: 6 week (post-treatment)

  5. Change in manometry of the pelvic floor muscles

    to assess the pressure levels performed by voluntary contraction of pelvic floor muscles (after 5 attempts); unit of measure - centimeter of water column (cmH2O); higher scores mean the better outcome

    Time frame: 6 week (post-treatment)

  6. Change in digital palpation of the pelvic floor muscles using PERFECT shame

    to assess power of pelvic floor muscles (P) - scoring scale 1-5 (higher is better), endurance (E) - scoring scale (higher is better), the ability to repeat the contraction with maximum strength (R) - scale 1-10 (higer is better); number of fast contractions (F) - scale 1-15 (higher is better); possibility of elevation of perineum (E) - yes/no; co-contraction of another muscles (C) - yes/no; involuntary contraction during coughing (T) - yes/no

    Time frame: 6 week (post-treatment)

07

Study locations

1 site
  • The rehabilitation clinic PROFEMED
    Warsaw, Poland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04366557
Lead sponsor
Katarzyna Jórasz
Responsible party
Katarzyna Jórasz (Principal Investigator, Józef Piłsudski University of Physical Education) — Sponsor-investigator
First posted
Apr 29, 2020
Start date
Jan 1, 2019
Primary completion
Apr 1, 2019
Completion
Mar 31, 2020
Last update
Apr 29, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion